Dataset

NG00037 - Progressive Supranuclear Palsy (PSP) GWAS

Overview

Progressive Supranuclear Palsy (PSP) is a movement disorder with prominent tau neuropathology. A genome wide association study of PSP was performed to identify genes that modify risk for this primary tauopothy. A two-stage analysis was performed to maximize efficiency while maintaining power. Stage 1 and Stage 2 are comprised of autopsied cases. While controls were used in the analysis, only genotypes for cases are provided here.

Molecular Data Type

Type

Disease

PSP
Submission date: 
10/21/2014
Samples

Stage 1: 1,112 Cases
 

Stage 2: 131 Cases

Phenotypes
Markers

Stage 1- 561,882

Stage 2- 5,283

 

Platform
PI Information